SILK vs. ATRI, TMCI, KIDS, SIBN, EMBC, FNA, IRMD, AORT, OFIX, and NVRO
Should you be buying Silk Road Medical stock or one of its competitors? The main competitors of Silk Road Medical include Atrion (ATRI), Treace Medical Concepts (TMCI), OrthoPediatrics (KIDS), SI-BONE (SIBN), Embecta (EMBC), Paragon 28 (FNA), Iradimed (IRMD), Artivion (AORT), Orthofix Medical (OFIX), and Nevro (NVRO). These companies are all part of the "surgical & medical instruments" industry.
Silk Road Medical (NASDAQ:SILK) and Atrion (NASDAQ:ATRI) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, risk, valuation, earnings, profitability, media sentiment, institutional ownership and dividends.
Atrion received 39 more outperform votes than Silk Road Medical when rated by MarketBeat users. Likewise, 55.84% of users gave Atrion an outperform vote while only 51.14% of users gave Silk Road Medical an outperform vote.
66.2% of Atrion shares are owned by institutional investors. 6.7% of Silk Road Medical shares are owned by company insiders. Comparatively, 22.7% of Atrion shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Atrion has a net margin of 11.46% compared to Silk Road Medical's net margin of -31.70%. Atrion's return on equity of 8.07% beat Silk Road Medical's return on equity.
Atrion has lower revenue, but higher earnings than Silk Road Medical. Silk Road Medical is trading at a lower price-to-earnings ratio than Atrion, indicating that it is currently the more affordable of the two stocks.
Silk Road Medical currently has a consensus price target of $22.18, suggesting a potential upside of 24.62%. Given Silk Road Medical's higher probable upside, equities analysts plainly believe Silk Road Medical is more favorable than Atrion.
Silk Road Medical has a beta of 1.48, suggesting that its share price is 48% more volatile than the S&P 500. Comparatively, Atrion has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500.
In the previous week, Atrion had 3 more articles in the media than Silk Road Medical. MarketBeat recorded 7 mentions for Atrion and 4 mentions for Silk Road Medical. Silk Road Medical's average media sentiment score of 0.48 beat Atrion's score of -0.10 indicating that Silk Road Medical is being referred to more favorably in the media.
Summary
Atrion beats Silk Road Medical on 12 of the 17 factors compared between the two stocks.
Get Silk Road Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for SILK and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SILK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Silk Road Medical Competitors List
Related Companies and Tools
